Treatment of COVID19 for Hospitalized Patients
Protocol: STUDY00005237
Full Title
A Multicenter Platform Trial of Putative Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
Description
The purpose of this study is to identify promising treatments and compare them to determine which are most effective and then move into studies that can prove their effectiveness. The study will be conducted at up to 40 sites throughout the US with 200 patients being enrolled. Participants will receive one of several investigational products and then be evaluated for outcomes related to their overall improvement. They will be monitored at all times for safety and any adverse reactions to the products.

Technical Description

(CSR 210104049566) The overall objective of the study is to evaluate the clinical efficacy and safety of different investigational therapeutics relative to the control arm among hospitalized adults who have COVID-19.

Keyword: COVID-19
Compensation: No
Eligibility
Admitted to a hospital with symptoms suggestive of COVID-19 and requires ongoing medical care.
Subject (or legally authorized representative) provides informed consent prior to initiation of any study procedures.
Subject (or legally authorized representative) understands and agrees to comply with planned study procedures.
Male or non-pregnant female adult ≥18 years of age at time of enrollment.
Age Group: Adults
Principal Investigator: CARLA FREDERICK
ClinicalTrials.gov: Open Study
Contact(s)
Judith Wilkins
jwilkins@ecmc.edu
+1 716-898-5066
Want to Learn More?
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.